ClearPoint Neuro CLPT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Biologics And Drug Delivery Disposable Products | $1.9M+6.5% | $2.4M+81.4% | $1.29M-37.3% | $1.87M+12.0% | $1.78M+222% | |
| Biologics And Drug Delivery | $4.81M+2.5% | $5.21M+22.7% | $4.4M-0.7% | $4.74M+9.5% | $4.69M+8.9% | |
| Biologics And Drug Delivery Services And License Fees | $2.91M+0.1% | $2.81M-3.8% | $3.11M+31.3% | $2.87M+8.0% | $2.91M-22.5% | |
| Capital Equipment And Software | $1.43M+177% | $502K-18.2% | $1.04M+24.8% | $1.04M+10.5% | $517K-63.2% | |
| Capital Equipment And Software Services | $413K+45.9% | $387K+41.8% | $390K+39.8% | $350K+35.7% | $283K+13.2% | |
| Capital Equipment And Software Systems And Software Products | $1.02M+336% | $115K-66.3% | $647K+17.2% | $694K+1.0% | $234K-79.7% | |
| Neurosurgery Navigation And Therapy Disposable Products | $5.89M+79.6% | $4.7M+61.4% | $3.42M+19.7% | $3.43M+32.7% | $3.28M+70.1% | |
| Neurosurgery Navigation And Therapy | $5.89M+79.6% | $4.7M+61.4% | $3.42M+19.7% | $3.43M+32.7% | $3.28M+70.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ClearPoint Neuro break its business down?
- ClearPoint Neuro (CLPT) reports revenue by product across 8 parts — Biologics And Drug Delivery Disposable Products, Biologics And Drug Delivery, Biologics And Drug Delivery Services And License Fees, Capital Equipment And Software and Capital Equipment And Software Services. Each is extracted from the segment footnotes and tracked over time.
- Where does ClearPoint Neuro's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ClearPoint Neuro's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
